Authorize the Food and Drug Administration to approve generic versions of biologic drugs and grant biologics manufacturers 12 years of exclusive use before generics can be developed.
Support comparative effectiveness research by establishing a non-profit Patient-Centered Outcomes Research Institute.
Establish a commissioned Regular Corps and a Ready Reserve Corps for service in time of a national emergency.
Reauthorize and amend the Indian Health Care Improvement Act.
Establish the Workforce Advisory Committee to develop a national workforce strategy.
Increase workforce supply and support training of health professionals through scholarships and loans.
Impose additional requirements on non-profit hospitals. Impose a tax of $50,000 per year for failure to meet these requirements.
Limit the deductibility of executive and employee compensation to $500,000 per applicable individual for health insurance providers.
Exclude unprocessed fuels from the definition of cellulosic biofuel for purposes of applying the cellulosic biofuel producer credit.
An unrelated tax increase of $4.5 B to clarify the application of the economic substance doctrine.